Healio
Healio

Read more

September 11, 2021
1 min read
Save

8 important updates for National Prostate Cancer Awareness Month

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

National Prostate Cancer Awareness Month is observed every September.

An estimated 248,530 men in the United States will be diagnosed with prostate cancer this year and about 34,130 men will die of the disease, according to American Cancer Society.

Prostate-specific antigen (PSA) test.
Source: Adobe Stock.

National Prostate Cancer Awareness Month is intended to educate men about prostate cancer risk factors, screening and treatment options.

In conjunction with the observance, Healio presents the following updates in prostate cancer research that may be relevant to your practice.

  1. Exercise appeared associated with decreased PSA levels, PSA velocity and prostate cancer cell growth among men with localized prostate cancer under active surveillance. Read more.
  2. Nomenclature for low-grade prostate cancer affected initial perception of the disease among online survey participants presented with a hypothetical clinical scenario. Read more.
  3. Black men with untreated, nonmetastatic prostate cancer appeared significantly less likely than white men to undergo prostatectomy during the first wave of the COVID-19 pandemic. Read more.
  4. Men with metastatic castration-resistant prostate cancer and obesity had a higher survival probability than overweight or normal-weight men. Read more.
  5. Combining an MRI-targeted biopsy approach with the Stockholm3 blood test for prostate cancer screening reduced overdetection while still identifying significant cancer. Read more.
  6. Adjuvant radiation therapy immediately after surgery improved survival among men with prostate cancer and high-risk features. Read more.
  7. An investigational targeted radioligand therapy improved outcomes for certain men with advanced prostate cancer. Read more.
  8. The addition of androgen deprivation therapy to radiation therapy did not appear associated with an increased risk for cardiovascular mortality among men with prostate cancer. Read more.
Sources/Disclosures

Collapse
Source:

Healio Reporting

Read more about

prostate cancer
prostate-specific antigen
androgen deprivation therapy
radiation therapy
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

 

Related Content